Cart
sales@molnova.com
APY0201
CAS No. 1232221-74-7
APY0201( APY0201 | APY-0201 | APY 0201 )
Catalog No. M10917 CAS No. 1232221-74-7
APY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM) that interrupts the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3,5)P2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 64 | In Stock |
|
| 5MG | 98 | In Stock |
|
| 10MG | 173 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 530 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAPY0201
-
NoteResearch use only, not for human use.
-
Brief DescriptionAPY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM) that interrupts the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3,5)P2.
-
DescriptionAPY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM) that interrupts the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3,5)P2; a unique small molecular IL-12/23 production inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsAPY0201 | APY-0201 | APY 0201
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPIKfyve
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1232221-74-7
-
Formula Weight413.48
-
Molecular FormulaC23H23N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC1=CC(/C=N/NC2=NC3=CC(C4=CC=NC=C4)=NN3C(N5CCOCC5)=C2)=CC=C1
-
Chemical Name(E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hayakawa N, et al. Bioorg Med Chem. 2014 Jun 1;22(11):3021-9.
molnova catalog
related products
-
Loureirin A
Loureirin A has an inhibitory effect on platelet activation perhaps through an impairment of PI3K/Akt signaling.Loureirin A negatively affects agonist-induced platelet aggregation such as collagen collagen-related peptide (CRP) ADP and thrombin.
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
Omipalisib
A highly potent dual inhibitor PI3K/mTOR inhibitor.
